Is it necessary to get the imported 13-valent pneumococcal vaccine?
Sep 24, 2024
Source: Cainiu Health
Dr. Yang Ziqi
Introduction
Individuals aged 65 years and older, patients with chronic diseases, and those with compromised immune systems—such as cancer patients undergoing chemotherapy or organ transplant recipients taking immunosuppressive drugs—are at higher risk of developing pneumonia due to their weakened immunity. Therefore, these individuals generally should receive the 13-valent pneumococcal vaccine. It is recommended that they seek medical advice at a hospital promptly.
If there are relevant high-risk factors, vaccination is generally recommended. If the full series of vaccinations has already been completed, additional doses are usually unnecessary. Specific analysis is as follows:
For older adults aged 65 and above, individuals with chronic diseases, and those with compromised immune systems—such as cancer patients undergoing chemotherapy or organ transplant recipients taking immunosuppressive drugs—the risk of developing pneumonia is higher due to weakened immunity. Therefore, these individuals are generally advised to receive the 13-valent pneumococcal vaccine.
Infants typically require four doses of the vaccine: one each at 2, 4, and 6 months of age, followed by a booster dose between 12 and 15 months. The exact vaccination schedule may vary depending on the region and local immunization program. If an infant has already completed the full vaccination series, no additional doses are needed.
It is recommended to visit a healthcare provider promptly, clarify individual circumstances, and follow medical advice regarding vaccination under professional guidance.
